Our upcoming events and latest news

Going green: How cannabis will steal share of wallet - April 11, 2018

The past few years have been quite eventful from macro, retail, and lifestyle perspectives. Healthcare uncertainty; new approaches to health and wellness; growing emphasis on natural products; and new shopper demands, expectations, and values have all been active drivers of change.

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study - April 11, 2018

Study Showcases Positive Impact of Medical Cannabis among Patients and Health Care Industry Chicago, IL – May 23, 2017 – Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study - the first of Illinois patients since the inception of the pilot program in 2012.

Drug Free America Believes Legal Weed Exploits the Opioid Epidemic - March 10, 2018

Advocates often say that legal marijuana has the potential to combat America's opioid crisis, but anti-pot groups are claiming just the opposite. In a recent letter sent to legislators in states with forms of legal marijuana, drug-prevention organization Drug Free America claims that pot use is associated with an increased risk of abusing prescription opioids and warns against using medical marijuana to treat opioid-use disorder.

Legal weed in Illinois? Imagine the possibilities. - January 12, 2018

When the day is done, my choice of a mellow relaxer usually comes out of a tallish green bottle. It's preferably named zinfandel, malbec or cabernet sauvignon, and definitely is on the full-bodied side, with more than a hint of a nose and absolutely tasty enough for some serious lip smacking.

Two New Studies Confirm, Again, That Cannabis Reduces Opioid Use - November 29, 2017

The first study, published in the journal PLOS One, was conducted by researchers at the University of New Mexico, who looked at 37 patients with chronic pain enrolled in New Mexico’s medical cannabis program and tracked them over a 21 month period.

Carmen Brace of Aclara Research Gives Legislative Testimony at Marijuana Legalization Hearing - November 28, 2017

Carmen Brace testified as an expert witness for the Illinois legislature, presenting the results of the Aclara Research Fall 2017 Study on the impact of cannabis on prescription drug and opioid usage.

Aclara Research Continues to Lead the Cannabis Industry with Release of Latest Study - November 28, 2017

Aclara’s Newest Study Shows Correlation between Medical Cannabis Use among Patients and Decrease of Prescription Opioid Usage

Study: 2 out of 3 Pain Patients Quit Opioids with Marijuana - November 9, 2017

In a new study conducted by Aclara Research, medical use of cannabis has once again been shown to be a successful substitute for dangerous addictive opioid painkillers for many patients in pain.

Aclara Research at the American Society of Consultant Pharmacists Annual Meeting, November 4th - September 14, 2017

Carmen Brace will jointly present the results of the latest Aclara Research study - Impact of Medical Cannabis on Prescription Drug and Opioid Usage- with Luba Andrus, RPh, VIce President of Patient Care, MedMar Dispensaries of Illinois, and Anne Berg, PharmD, at the American Society of Consultant Pharmacists (ASCP) Annual Meeting.

Aclara Research joins the 1st Annual Lake County Canna EXPO - August 1, 2017

Carmen Brace joins Illinois medical professionals and dispensary owners to present the results of the Illinois Patient Experience study at the Lake County Canna Expo. Join us to learn more about your questions regarding medical cannabis.

Carmen Brace speaking at Southeast Michigan Cannabis Business Development Conference on July 9, 2017 - July 6, 2017

Carmen joins a panel of colleagues in Michigan cannabis industry to discuss the experience of entrepreneurship as a consumer insights research professional, a woman and as a person of color.

Illinois Medical Cannabis Patient Study Shows Positive Impact on Pain - June 1, 2017

he results of the largest and most comprehensive look at the impact of the Illinois Medical Cannabis Patient Experience Study – a statewide program that has examined patients since 2012 – shows the positive impact of medical cannabis among patients and the health care industry.

Study finds women behind surge in CBD use in Illinois - May 26, 2017

A study of patients in Illinois suggests that CBD products are nearly as popular as THC products, and that women are the driving force behind sales of the former. The Illinois Medical Cannabis Patient Experience Study – conducted by Aclara Research, a Chicago medical marijuana patient research firm – found that 47% of patients said they use CBD daily and 22% had no previous experience with marijuana before joining the state’s MMJ program.

New Study Details Positive Impact of Illinois’ Medical Marijuana Program - May 24, 2017

A new research study conducted on patients enrolled in Illinois' pilot medical marijuana program has found that cannabis treatments have helped patients cut back on prescription drug use, or even quit entirely. Medical cannabis consulting firm Aclara Research recently released The Illinois Medical Cannabis Patient Experience Study, the first study on the effectiveness of the state's pilot MMJ program, which was launched in 2012.

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study - May 23, 2017

Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study – the first of Illinois patients since the inception of the pilot program in 2012. The study is the largest and most comprehensive look at the impact of the statewide program, examining nearly 300 of the 18,000 Illinois residents registered.

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study - May 23, 2017

CHICAGO, May 23, 2017 (GLOBE NEWSWIRE) -- Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study - the first of Illinois patients since the inception of the pilot program in 2012. The study is the largest and most comprehensive look at the impact of the statewide program, examining nearly 300 of the 18,000 Illinois residents registered.